1Y Annualised Return
▼-25.83%
3Y Annualised Return
▲16.46%
5Y Annualised Return
▲19.60%
|
|
|
Over the past
Market Cap (in crs)
414.16
Face Value
10
Turnover (in lacs)
12.18
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
81.37 Cr | 82.5 Cr | 89.11 Cr | 84.6 Cr | 78.46 Cr |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
349.58 Cr | 309.79 Cr | 318.63 Cr | 351.81 Cr | 267.37 Cr | 263.06 Cr |
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
6.43 Cr | 4.38 Cr | 3.48 Cr | 4.85 Cr | 3.3 Cr |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
18.73 Cr | 6.33 Cr | 11.38 Cr | 25.3 Cr | 13.56 Cr | 10.18 Cr |
SMS Lifesciences India Ltd reported a 2.0% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 1.6%.
Its expenses for the quarter were down by 4.1% QoQ and 3.3% YoY.
The net profit increased 46.2% QoQ and increased 94.5% YoY.
The earnings per share (EPS) of SMS Lifesciences India Ltd stood at 20.19 during Q2 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 1141 Rs | 1141 Rs |
Week Rs | 1779 Rs | 2796 Rs |
Month Rs | 2238 Rs | 3475 Rs |
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
18.50 | 414.88 | 13.05 | 44.41 | 17.42 | 21.79% | 19.28% | -25.91% | -45.91% | -12.74% | 0.00% | 0.00 | 41.73 | 0.58 | |
413.45 | 401.48 | 137.6 | 477 | 423.00 | -2.82% | 5.50% | -4.70% | 190.75% | 229.18% | 0.00% | 60.71 | 41.73 | 5.54 | |
362.35 | 437.00 | 305 | 625 | 363.15 | 6.26% | -14.95% | -13.35% | 17.36% | 328.31% | 0.00% | 0.00 | 41.73 | 18.18 | |
312.75 | 364.10 | 222 | 324.95 | 301.15 | 0.63% | 4.25% | 8.61% | 7.20% | 123.23% | 0.00% | 23.05 | 41.73 | 4.34 | |
67.11 | 364.49 | 65.3 | 120.92 | 67.75 | -4.14% | -18.89% | -33.02% | -37.39% | 0.00% | 0.00% | 53.13 | 41.73 | 1.15 | |
108.00 | 419.36 | 99.99 | 154.4 | 105.89 | -2.84% | -11.47% | 0.00% | 0.00% | 0.00% | 0.00% | 29.68 | 41.73 | 1.97 |
Haleos Labs share price is ₹1369.9 in NSE and ₹1390 in BSE as on 2/12/2025.
Haleos Labs share price in the past 1-year return was 16.29. The Haleos Labs share hit a 1-year low of Rs. 959.8 and a 1-year high of Rs. 1680.
The market cap of Haleos Labs is Rs. 414.16 Cr. as of 2/12/2025.
The PE ratios of Haleos Labs is 22.07 as of 2/12/2025.
The PB ratios of Haleos Labs is 2.03 as of 2/12/2025
You can easily buy Haleos Labs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Haleos Labs share price is ₹1680 and ₹959.8 as of 2/12/2025.
The earnings per share (EPS) of SMS Lifesciences India stood at 20.19 during Q2 FY 2025-26.
Please be aware that Haleos Labs stock prices are subject to continuous fluctuations due to various factors.